Shimizu C et al [22] reported that IGF-IR was overexpressed in 43.8% of breast tumors, whereas Railo MJ et al [23] have shown a positive IGF-IR expression in 39% of breast cancer samples. This evidence concerns the gene IGF1R and breast carcinoma.